1-3 of 3
Hil Hsu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Interim PET/CT Scan Use during Frontline (1L) Therapy and Subsequent Treatment Characteristics in Patients with Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Ran Reshef, Constance Lau, Hil Hsu, Brett Doble, Clare Spooner, Anik R Patel, Liana Nikolaenko
Journal: Blood
Blood (2024) 144 (Supplement 1): 7775.
https://doi.org/10.1182/blood-2024-200288
Published: 2024
Journal Articles

The Patient Journey and Treatment Outcomes Comparing Inpatient Versus Outpatient Axicabtagene Ciloleucel in Non-Hodgkin's Lymphoma (NHL) - a Large, Multicenter Study

Minoo Battiwalla, Shanna Arnold Egloff, Betsy Blunk, Casey Martin, Meredith Mattlin, Katie Culos, Hil Hsu, Timothy Best, Nosha Farhadfar, Michael T. Tees, Uttam K Rao, John Mathews, Priya Amin, Rocky L. Billups, Tonya Cox, Navneet Majhail
Journal: Blood
Blood (2024) 144 (Supplement 1): 3734.
https://doi.org/10.1182/blood-2024-207777
Published: 2024
Journal Articles

Treatment Patterns and Predictors of Survival after First Line Therapy in Large B-Cell Lymphoma in a Real-World US Cohort

Joseph P. McGuirk, Mark Fesen, Scott D. Ramsey, Rony Abou-Jawde, Anthony Proli, Hil Hsu, Anik R Patel, Miguel-Angel Perales, Blythe Adamson, Jiarui Fu, Jeremy Snider
Journal: Blood
Blood (2024) 144 (Supplement 1): 2367.
https://doi.org/10.1182/blood-2024-208283
Published: 2024